Colorado BioScience Association (CBSA) will hold its BioWest Conference, September 10, 2014, at the Marriott City Center, Denver. The three finalists in the 2014 Venture Showcase competition at BioWest include: dBMEDx, Littleton; KromaTiD, Inc., Fort Collins; Mighty Oak Medical, Englewood.
Denver, CO, August 19, 2014 -- The Colorado BioScience Association (CBSA) announces the 2014 BioWest Conference, September 10, at the Marriott City Center, 1701 California Street, Denver. The announcement is made by CBSA President & CEO April Giles, who says, “BioWest is the Rocky Mountain region's premier medical device and biotechnology conference that brings together the industry for a one-day only conference that includes the Venture Showcase competition."
The Venture Showcase finalists pitch their technologies and business plans in front of a live audience at BioWest to a panel of bioscience experts and venture capitalists. The winner, announced at the end of the conference day, will receive a $7,500 cash prize.
The three finalists in the 2014 Venture Showcase competition include:
dBMEDx - Littleton
dBMEDx is developing breakthrough, real-time clinical decision and patient monitoring devices using our patented, non-invasive scanning technology. Visit: http://www.dbmedx.com
KromaTiD, Inc. - Fort Collins
KromaTiD is dedicated to creating new products for disease research, mutation detection and chromosome analysis. Visit: http://www.kromatid.com
Mighty Oak Medical - Englewood
Mighty Oak is developing a prize-winning spine technology that features an affordable and disposable option for surgical navigation. Visit: http://www.mightyoakmedical.com
About BioWest 2014 | September 10, 2014
The BioWest Conference is a one day event attended by more than 300 industry leaders, government representatives, executives, researchers, investors and entrepreneurs.
The conference features speakers Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration (her ‘Update on the FDA’ keynote will occur at 4:45 p.m.) and keynote panelists; Jandel Allen-Davis, M.D., Vice President, Government and External Relations, Kaiser Permanente Colorado; James Hill, Ph.D. is Professor of Pediatrics and Medicine at the University of Colorado School of Medicine; Len Tacconi, President, HMR Weight Management Services Corp., a subsidiary of Merck & Co. Inc.; and Russell Slifer, Director, United States Patent & Trademark, Rocky Mountain Regional Office. The full schedule of the day’s events is found at: http://www.cobioscience.com/biowest/schedule
Conference Registration is now open at http://www.CoBioScience.com/BioWest
. Rates for members start at $325 and $375 for non-members and passes for the expo hall & reception only are $125 for members and $150 for non-members. Group rates are available for companies and organizations.
The conference also includes an Exhibit Hall with over 40 exhibitors showcase new technologies, products and services to attendees.
New BioWest Pre-Event Sept 9: Digital Health Venture Showcase
In collaboration with the PrIME Health Collaborative, CBSA is co-hosting the BioWest pre-event, the 2014 Digital Health Venture Showcase on September 9 (1 to 9 p.m.) at CSU Denver, 475 17th Street, 2nd Floor Atrium (this is the final pitch event for the Finance Track of PrIME’s Digital Health Challenge). The event will feature a curated, vetted selection of pitches from the best and brightest Colorado digital health companies. These finalist companies will vie for a share of $50,000 in prizes awarded by PrIME in partnership with the Colorado Health Foundation. To register, visit: http://cobioscience.site-ym.com/events/event_details.asp?id=487688
Note: the final pitch event for the Access Track of PrIME’s ‘Digital Health Challenge @ Denver Startup Week’ is on September 17th, where finalists will pitch live in front of a panel of health care executives and a group of more than 100 interested onlookers. For more information, visit: http://primehealthco.com/about/challenge/
About Colorado BioScience Association
CBSA is a not-for-profit organization providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to promote the growth of the industry by advocating for a better business environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the state, and speaking with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com